Ultragenyx Pharmaceutical Inc. buy Jefferies Financial Group Inc.
Start price
30.12.25
/
50%
€17.00
Target price
30.12.26
€53.50
Performance (%)
17.06%
Price
22.01.26
€19.30
Summary
This prediction is currently active. The prediction currently has a performance of 17.06%. This prediction currently runs until 30.12.26. The prediction end date can be changed by Jefferies_Financial_ at any time. Jefferies_Financial_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| Ultragenyx Pharmaceutical Inc. | -3.500% |
| iShares Core DAX® | -1.673% |
| iShares Nasdaq 100 | -1.346% |
| iShares Nikkei 225® | -1.529% |
| iShares S&P 500 | -1.702% |
Comments by Jefferies_Financial_ for this prediction
In the thread Ultragenyx Pharmaceutical Inc. diskutieren
Ultragenyx Pharmaceutical (NASDAQ:RARE) had its price target lowered by analysts at Jefferies Financial Group Inc. from $114.00 to $63.00. They now have a "buy" rating on the stock.
Ratings data for RARE provided by MarketBeat